A2P SMS Market Poised to Surge From US$ 55.0 Bn in 2014 to US$ 70.00 Bn Globally by 2020, Growing at 4.0% CAGR- Market Research Store

Dec 07, 2015 07:10 am UTC| Business

Deerfield Beach,FL, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “A2P SMS Market for Pushed Content Services, Customer Relationship Management Services, Promotional Campaigns,...

X-Ray Security Screening Market Size Worth USD 2.89 Billion By 2020 : Radiant Insights,Inc

Dec 07, 2015 06:10 am UTC| Business

San Francisco, Dec. 07, 2015 (GLOBE NEWSWIRE) -- The global X-ray Security Screening Market is expected to reach USD 2.89 billion by 2020. Threats pertaining to piracy, drug trade, cross-border terrorism, human...

Abdominal Surgical Robots Market Size, Share And Growth Report To 2021 : Radiant Insights,Inc

Dec 07, 2015 05:51 am UTC| Business

San Francisco, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Intuitive Surgical owns the market as the sole participant with measurable market share in abdominal surgical robots.  This leadership position will need to be defended as...

TG Therapeutics, Inc. Announces Data Presentations at the 57th American Society of Hematology Annual Meeting From Ongoing Clinical Studies in Patients With Non-Hodgkins Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Dec 06, 2015 23:00 pm UTC| Business

Combination of TG-1101 plus TGR-1202 (“TG-1303”) continues to demonstrate a favorable safety profile, with only 8% of patients discontinuing due to an adverse event and no cases of colitis reported to date 80% (8 of 10)...

MediciNova Announces Presentation Regarding Clinical Trial of MN-166 (ibudilast) in ALS at the 6th Annual California ALS Pac10 and Research Network Meeting at UCSD, La Jolla, California　

Dec 06, 2015 23:00 pm UTC| Business

LA JOLLA, Calif., Dec. 06, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875),...

Calithera Biosciences Reports Phase I Data for CB-839 in Patients With Hematological Malignancies at the 57th American Society of Hematology Annual Meeting

Dec 06, 2015 15:26 pm UTC| Business

First results of CB-839 dosed in combination therapy Promising clinical activity with early signs of biologic activity, tolerability, and durability SOUTH SAN FRANCISCO, Calif., Dec. 06, 2015 (GLOBE NEWSWIRE) -- ...

Lynch Chiropractic Shares Tips for Natural Cold and Flu Defense

Dec 06, 2015 15:00 pm UTC| Business

LEXINGTON, Ky., Dec. 06, 2015 (GLOBE NEWSWIRE) -- Lexington chiropractor Dr. Kevin Lynch is sharing his tips to help patients reduce the likelihood for contracting the flu during the winter months. Flu and cold season...